![](/img/cover-not-exists.png)
RATIONALE FOR CNP520 DOSE SELECTION FOR THE PIVOTAL CLINICAL PROGRAM IN PRECLINICAL AD
Lopez-Lopez, Cristina, Ufer, Mike, Rouzade-Dominguez, Marie-Laure, Pezous, Nicole, David, Olivier, Kolly, Carine, Tariot, Pierre, Reiman, Eric M., Vargas, Gabriel, Lenz, Robert, Graf, Ana, Neumann, UlVolume:
13
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2017.07.245
Date:
July, 2017
File:
PDF, 402 KB
english, 2017